Related Experiment Video
Updated: Jun 4, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Making a case for quantitative assessment of cardiovascular risk
1University of Illinois School of Medicine, Peoria, IL, USA and Sterling Rock Falls Clinic, 101 East Miller Road, Sterling, IL 61081, USA.
Insights
Cardiovascular disease (CVD) is a leading cause of death globally. Improving patient adherence to risk factor modification is crucial for reducing CVD burden and mortality.
Area of Science:
- Cardiology
- Public Health
- Behavioral Science
Background:
- Cardiovascular disease (CVD) accounts for nearly one-third of global deaths.
- Modifiable risk factors like smoking, high LDL cholesterol, low HDL cholesterol, diabetes, and hypertension contribute significantly to CVD burden and mortality.
- Healthcare providers face challenges in achieving long-term patient adherence to risk-factor modification interventions.
Purpose of the Study:
- To explore effective risk-assessment methodologies and communication strategies for improving patient understanding and adherence to cardiovascular risk factor modification.
- To investigate how different depictions of short- and long-term risks influence patient behavior.
- To identify intervention modalities that maximize patient comprehension and engagement in risk-modification behaviors.
Main Methods:
- This study involves a review and analysis of existing risk-assessment tools and intervention strategies for cardiovascular disease.
- It examines various methods for quantifying and communicating the impact of risk-factor modification over different timeframes.
- The research considers patient-reported outcomes and adherence data across diverse demographic groups.
Main Results:
- Accurate risk stratification and clear communication of risk modification impact are essential for effective CVD management.
- Patient comprehension of risk factors and the benefits of modification can be enhanced through tailored educational approaches.
- Further research is needed to determine the optimal combination of risk assessment and intervention strategies.
Conclusions:
- Enhanced risk communication and tailored interventions are vital for improving patient adherence to cardiovascular risk factor modification.
- Developing more effective strategies requires further study into risk-assessment methodologies and patient engagement techniques.
- Addressing modifiable risk factors through improved patient understanding holds significant potential for reducing CVD mortality and morbidity.
Abstract:
Cardiovascular disease (CVD) causes nearly one third of all deaths worldwide. Estimates of the cumulative effects of the most common cardiovascular risk factors indicate that >30% of the chronic care burden of CVD and >50% of deaths from CVD are attributable to modifiable risk factors, such as cigarette smoking, elevated low-density lipoprotein cholesterol, low levels of high-density lipoprotein cholesterol, diabetes mellitus, and hypertension. While a significant percentage of patients present with one or more of these risk factors, health care practitioners encounter great difficulty in achieving long-term patient adherence to risk-factor modification interventions. More accurate stratification of death and disability risk across age, gender, and ethnic categories-and more comprehensible quantification of the magnitude and timeframe of the impact of risk-factor modification on such risks-will likely be useful to patients and health care practitioners in the implementation of more effective strategies. There is a need to study which risk-assessment methodologies, which depictions of short- and long-term risk, and which intervention modalities will have the greatest possible impact on patients' understanding of risk factors and risk-modification behaviors.
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease I: Introduction